The company's expertise lies in identifying the targets and off-targets at the cell membrane on living cells using the ligand-receptor capture LRC-TriCEPS™ technology. This technology can be used to identify targets for proteins, peptides, viruses, and even small molecules. Dualsystems Biotech is a service provider for custom proteomics for both industry and academia, and with their Flow-TriCEPS™ technology, they can optimize binding conditions prior to the main identification experiment. The company has built a solid investor base through two financing rounds and focuses exclusively on their mass spectrometry-based CaptiVate and CaptiRec technologies.